The overall survival time of patients with overexpression of YAP1 in esophageal cancer is longer than those with low expression, which is contrary to our results of meta-analysis (MST: 1361 vs. 763 days, P < 0.0001) (Figure 5). This evidence concerns the gene YAP1 and esophageal cancer.